Differential clinicopatho-logical and molecular features

Differential clinicopathological and molecular features within late-onset colorectal cancer according to tumor location

BACKGROUND:

Since there is a predilection of some clinical and molecular features for a given tumor location, we assessed whether this can be confirmed in late-onset colorectal cancer (LOCRC).

RESULTS:

Right colon cancers showed features associated with sporadic Microsatellite Instability: predominance of female cases and BRAFmutations, and an important mucinous component. Left colon cancers developed a higher number of polyps and multiple primary CRCs, showed the strongest familial component, and had better prognosis. Rectal cancers showed a predominantly sporadic phenotype, with worse prognosis and a CpG Island Methylator Phenotype (CIMP)-High. No copy number alterations (CNAs) greater than or equal to 50% were observed in this LOCRC group, and the most recurrent alterations were losses at 5q13 and 14q11, and gains at 7q11, 7q21-q22, 19p13-p12, 19q13 and 20p11-q11. KRAS and PIK3CA were the only mutated genes showing differences according to the tumor location, mainly for right colon cancers.

MATERIALS AND METHODS:

We analyzed clinical and molecular characteristics of LOCRC at different tumor locations in order to determine if there are differential phenotypes related with the location in the colon.

CONCLUSIONS:

Categorizing LOCRC according to tumor location appears to be an adequate first step to resolving the heterogeneity of this subset of CRC.

Full article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880605/

2019-03-20T00:04:07+00:00